← Browse by Condition
Medical Condition

myeloproliferative chronic myelomonocytic leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05365035 Phase 2
Recruiting

A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts

Enrollment
60 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →